The World Market for Cancer Therapeutics: Forecasts to 2020 (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

    Published: November 12, 2015 | Price: $2,100.00 – $4,200.00

    This report, the World Market for Cancer Therapeutics presents a detailed picture of the market for cancer drugs, with a focus on novel therapies. The market analysis in this report includes analysis of products avaiable for each cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Colon Cancer and Other types) including Monoclonal Antibodies, Tyrosine Kinase, Inhibitors, Cancer Vaccines, Cytokines, Gene Therapy, Traditional Chemotherapy. The report has a special emphasis on novel treatments and provides an overview of...
    Needle-Free Drug Injection Systems and Safety Syringes: The Market for Alternatives to Traditional Needle-Based Delivery

    Published: February 18, 2006 | Price: $2,200.00 – $5,990.00

    Biopharmaceutical research and development is sure to dramatically increase the number of injectable drugs coming to market over the next few years. While advanced drug delivery techniques continue to hold promise for unique methods of administration, the traditional injection is still the dominant paradigm. However, the staggering costs and intransigent safety problems associated with sharps, along with consumer demand and the move to alternate-site care, are pushing for alternatives to traditional needles and syringes faster than advanced delivery technologies can...
    Rheumatoid Arthritis: The 45 Market in the United States for Drugs and Biologics

    Published: November 1, 2003 | Price: $2,246.00 – $4,492.00

    Rheumatoid arthritis is a progressive disease of the joint structure that may be localized or systemic. It varies significantly in severity, producing symptoms that range from minor aches to severe disability and joint deformity. While rheumatoid arthritis can be diagnosed at any age, for childhood to the later years, it most commonly presents with significant symptoms at about middle age. From that point, the disease can progress quickly, slowly or virtually not at all. With an aging population, the unmet...
    Contract Manufacturing in Syringes, Catheters, Hip and Knee Implants, Air Pathways and other High Growth Markets

    Published: September 1, 2008 | Price: $2,250.00 – $5,500.00

    Contract Manufacturers seeking to partner with global marketers can find the best opportunities making the medical devices that drive the best sales and growth for global marketers. This report covers contract manufacturing (CM) in several medical devices that show promising growth for the next five years. The report details the following areas and provides forecasts for the next five years:   Cardiac Pace Makers Implantable Defibrillators Catheters Syringes Orthopedic Hip Implants Orthopedic Knee Implants Oxygen Concentrators (Standard and Portable) Continuous...
    The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry)

    Published: January 1, 2016 | Price: $2,396.00 – $4,792.00

    The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others) In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing...
    IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast)

    Published: October 4, 2016 | Price: $2,396.00 – $4,792.00

    IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast)    In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. The Middle East is an underserved region with large market potential. IVD in the Middle East provides data on the developments in the IVD industry in the Middle East, including: Egypt...
    The World Market for Personalized Medicine Tests for Cancer

    Published: January 19, 2017 | Price: $2,396.00 – $4,800.00

    The World Market for Personalized Medicine Tests for Cancer This report, Personalized Medicine Tests for Cancer, provides an authoritative look at the market for companion and personalized medicine testing for cancer. The report includes a market size and forecast for personalized medicine testing by geography (US, EU, ROW). Company profiles are included and products are identified by status (on the market, in development)
    OEM Contract Manufacturing in Medical Devices, Vol I: Materials Processing

    Published: August 1, 2007 | Price: $2,400.00 – $6,990.00

    Abundant opportunities are available for manufacturing companies who enter the outsourcing medical device manufacturing market; but the market is competitive and information has been hard to obtain. Original equipment manufacturers are finding new opportunities with managers located at the corporate headquarters or main manufacturing/assembly operations continually reviewing manufacturing costs and looking to outsourcing for cost efficiency. Kalorama's OEM Contract Manufacturing in Medical Devices Series presents a total study of market for outsourcing in medical devices. It features an exhaustive three-way...
    Healthcare-Associated Infection Testing (HAI) – The “Prevention Effect” on Diagnostic Markets

    Published: September 7, 2017 | Price: $2,400.00 – $4,800.00

    This report takes a look at both prevention procedures such as sterilization and surface area disinfection and testing such as molecular tests and immunoassays.  Infection control in healthcare facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of healthcare is known as a nosocomial, or hospital acquired, infection. What...
    Drug Delivery Markets, Vol III – Pulmonary Delivery Systems

    Published: March 1, 2007 | Price: $2,495.00 – $4,990.00

    The lungs are considered by many to be the best alternative for drugs needing to bypass the gastrointestinal tract. With advancing technology, the practice of utilizing the huge surface area of the lungs to delivery drugs into the blood circulation has been slowly transforming into reality. The pulmonary drug delivery market reached $25.5 billion in 2006 and is expected to experience high steady growth in the next five years. Contributing to growth are new technologies such as dry powder inhalers...
    Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery

    Published: April 1, 2007 | Price: $2,495.00 – $4,990.00

    New biological treatments are being developed at a record pace, but their potential could be compromised by a significant obstacle: the delivery of these drugs into the body. Pharmaceutical delivery is now nearly as important as product. Kalorama's Drug Delivery Markets Series covers these new systems. The fourth volume of this series, Kalorama's Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery is a complete overview of a delivery mechanism that offers some advantages: low pain, infection risk, fewer...
    World Market for Anti-infectives Volume II: The World Market for Antibacterial Medications, The

    Published: January 1, 2003 | Price: $2,500.00 – $5,000.00

    Antibiotic development has never proceeded at this pace or with this much urgency. Demand for effective antibacterial compounds is growing rapidly and companies are trying to fill their pipelines with products that can meet the challenges of increasingly stubborn infectious agents. By far the largest of the anti-infective segments, antibacterials represent approximately 65% of the $20 billion world market in infectious disease drugs. However, it’s also the most crowded of the segments with big pharma and small biotech companies alike...
    World Market for Anti-Infectives, Volume I: Antifungals, The

    Published: April 1, 2005 | Price: $2,500.00 – $5,000.00

    In the past 100 years, there has been a steady increase in the incidence of serious secondary systemic fungal infections. One of the factors aiding the spread of fungal disease has been the widespread use of broad-spectrum antibiotics, which eliminate or decrease the non-pathogenic bacterial populations that normally compete with fungi. Another has been the vast increase in populations with with compromised immune response (caused by AIDS or by the action of immunosuppressant drugs or cancer chemotherapy agents). In addition...
    The World Market for Anti-Infectives, Volume II – Antibacterials

    Published: May 1, 2005 | Price: $2,500.00 – $5,000.00

    For the past 60 years, antibiotic drugs have changed bacterial infections from the life-threatening scourges they once were into eminently treatable conditions. However, the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant to traditional agents. As a result, pharmaceutical companies are taking a second look at the antibiotic market, after more than two decades of relative complacency. In addition to the scientific and technical challenges of new antibiotic development, there are significant...
    The World Market for Anti-Infectives, Volume III – Antivirals

    Published: June 1, 2005 | Price: $2,500.00 – $5,000.00

    This volume of Kalorama Information’s World Market for Anti-Infectives series focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease Inhibitors Other Misc. Antivirals The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides an An overview Description of products on the market Description of products in development Market estimates and forecasts through 2009 Market segmentation by infection type Market segmentation by geographic region Market share of leading...